(Q33390284)

English

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function (English)

1 reference

Europe PubMed Central

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

object named as

Meletios Dimopoulos

1

0 references

Hartmut Goldschmidt

4

object named as

Hartmut Goldschmidt

1 reference

Europe PubMed Central

26 July 2017

Edward A. Stadtmauer

3

object named as

Edward A Stadtmauer

1 reference

Europe PubMed Central

26 July 2017

author name string

Adrian Alegre

2

1 reference

Europe PubMed Central

26 July 2017

Jeffrey A Zonder

5

1 reference

Europe PubMed Central

26 July 2017

Carlos M de Castro

6

1 reference

Europe PubMed Central

26 July 2017

Zvenyslava Masliak

7

1 reference

Europe PubMed Central

26 July 2017

Donna Reece

8

1 reference

Europe PubMed Central

26 July 2017

Marta Olesnyckyj

9

1 reference

Europe PubMed Central

26 July 2017

Zhinuan Yu

10

1 reference

Europe PubMed Central

26 July 2017

Donna M Weber

11

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

1 August 2010

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

116

1 reference

Europe PubMed Central

26 July 2017

3807-3814

1 reference

Europe PubMed Central

26 July 2017

16

1 reference

Europe PubMed Central

26 July 2017

Pathogenesis and treatment of renal failure in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Renal failure in multiple myeloma: incidence, correlations, and prognostic significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

International uniform response criteria for multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Clinical review: specific aspects of acute renal failure in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Renal, hematologic and infectious complications in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

21 June 2018

Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

31 October 2018

Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

31 October 2018

Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

31 October 2018

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2970911

31 October 2018

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564094

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal Failure in Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564094

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564094

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564094

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.25139

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33390284&oldid=1572315749"